EAGLE HEALTH INVESTMENTS LP
Q3 2022 Form 13-F
GREENWICH, CONNECTICUT
CIK 0001842545
· CRD 309210
· SEC-registered investment adviser
$435.7M Reported Value Total
EAGLE HEALTH INVESTMENTS LP reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $637,089,261, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $605.3M gross asset value
Hedge Fund: $605.3M
Source: Form ADV filed 2026-03-28
Reported value
$435.7M
Quarter over quarter
+2.7%
Holdings
28
Top-10 concentration
65.7%
Key People
Form ADV owners & control persons
Gary Johnathan Stern
FOUNDER AND CHIEF INVESTMENT OFFICER
Michelle Nmn Dea
CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2022 13F record
Q3 2022 13F filing summary
| Period of report | September 30, 2022 |
|---|---|
| Filed | November 14, 2022 |
| Form | 13F-HR |
| Reported value | $435.7M |
| Positions | 28 |
| Change in reported value | +1.6% |
| New positions | 1 |
| Exited positions | 1 |
| Position turnover | 6.9% |
| Top-10 concentration | 65.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 10, 2026
|
27 | $603.3M |
|
Q1 2026 13F
Filed May 15, 2026
|
26 | $571.8M |
|
Q4 2025 13F
Filed Feb 6, 2026
|
30 | $455.1M |
|
Q3 2025 13F
Filed Nov 7, 2025
|
23 | $380.9M |
|
Q2 2025 13F
Filed Aug 12, 2025
|
21 | $405.2M |
|
Q1 2025 13F
Filed May 12, 2025
|
20 | $385.1M |
|
Q4 2024 13F
Filed Feb 12, 2025
|
18 | $407.9M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
24 | $528.0M |
|
Q2 2024 13F
Filed Aug 13, 2024
|
25 | $570.2M |
|
Q1 2024 13F
Filed May 14, 2024
|
26 | $538.2M |
|
Q4 2023 13F
Filed Feb 12, 2024
|
22 | $492.1M |
|
Q3 2023 13F
Filed Oct 27, 2023
|
23 | $453.8M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
27 | $534.8M |
|
Q1 2023 13F
Filed May 12, 2023
|
27 | $513.7M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
27 | $433.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
28 | $435.7M |
|
Q2 2022 13F
Filed Aug 11, 2022
|
28 | $428.9M |
|
Q1 2022 13F
Filed May 12, 2022
|
28 | $405.9M |
|
Q4 2021 13F
Filed Feb 10, 2022
|
28 | $410.4M |
|
Q3 2021 13F
Filed Oct 20, 2021
|
27 | $315.3M |
3 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ILMN ILLUMINA INC | $40.7M | 9.34% |
| 2 | IQV IQVIA HLDGS INC | $36.2M | 8.31% |
| 3 | ALNY ALNYLAM PHARMACEUTICALS INC | $32.4M | 7.43% |
| 4 | UTHR UNITED THERAPEUTICS CORP DEL | $29.5M | 6.76% |
| 5 | HUM HUMANA INC | $28.7M | 6.58% |
| 6 | NTRA NATERA INC | $26.1M | 5.99% |
| 7 | CANO CANO HEALTH INC | $24.5M | 5.63% |
| 8 | SGEN SEAGEN INC | $23.9M | 5.49% |
| 9 | ISRG INTUITIVE SURGICAL INC | $22.8M | 5.23% |
| 10 | DXCM DEXCOM INC | $21.4M | 4.91% |
| 11 | ARGX ARGENX SE | $21.3M | 4.89% |
| 12 | AZN ASTRAZENECA PLC | $20.7M | 4.76% |
| 13 | OM OUTSET MED INC | $19.7M | 4.53% |
| 14 | INSP INSPIRE MED SYS INC | $17.8M | 4.09% |
| 15 | AMWL AMERICAN WELL CORP | $13.0M | 2.99% |
| 16 | TNDM TANDEM DIABETES CARE INC | $9.4M | 2.16% |
| 17 | AGIO AGIOS PHARMACEUTICALS INC | $9.3M | 2.14% |
| 18 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | $8.7M | 1.99% |
| 19 | GH GUARDANT HEALTH INC | $8.2M | 1.88% |
| 20 | AXNX AXONICS INC | $7.8M | 1.79% |
Values as reported on the Q3 2022 Form 13F. Every position is in the holdings table below.